Issue

Vol. 34 No. 9 (2022): Vol 34 Issue 9

Copyright (c) 2022 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Novel Analytical Approach for the Estimation of Oxalic Acid Content in Sodium Ascorbate by Reversed Phase-High Performance Liquid Chromatography

https://doi.org/10.14233/ajchem.2022.23803
Rajiv A. Jadhav
Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad-431006, India; Department of Chemistry, Deogiri College, Aurangabad-431004, India
A.S. Joshi
Department of Chemistry, Deogiri College, Aurangabad-431004, India
P.R. Pawar
Department of Chemistry, Deogiri College, Aurangabad-431004, India
V.K. Ahirrao
Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad-431006, India
S.R. Bembalkar
Department of Chemistry, Deogiri College, Aurangabad-431004, India

Corresponding Author(s) : S.R. Bembalkar

s_bembalkar@yahoo.com

Asian Journal of Chemistry, Vol. 34 No. 9 (2022): Vol 34 Issue 9

Abstract

A simple and novel reverse phase-high performance liquid chromatography (RP-HPLC) method employing Triart C18 column has been developed and validated for the estimation of oxalic acid content in sodium ascorbate drug substance and drug product. Forced degradation study of sodium ascorbate was performed at acid, base, oxidative, photolytic and thermal stress conditions. Oxalic acid was found as final degradants. The separation was achieved in isocratic mode using mixture of tetrabutylammonium hydroxide-phosphate buffer (pH 7.0) and acetonitrile in the ratio of 80:20; v/v as mobile phase at a flow rate of 1.0 mL min–1 using UV detector. The method was validated as per the ICH guideline (Q2R1) for accurate and precise quantification of oxalic acid content in sodium ascorbate. The obtained limit of quantification of oxalic acid was 0.034%. Mean recovery of oxalic acid was found to be 98.9 ± 8.7%. Presented method could be applied for the estimation of oxalic acid content in sodium ascorbate at pharmaceutical laboratories.

Keywords

Sodium ascorbate Ascorbic acid Oxalic acid Forced degradation Method validation
A. Jadhav, R., Joshi, A., Pawar, P., Ahirrao, V., & Bembalkar, S. (2022). Novel Analytical Approach for the Estimation of Oxalic Acid Content in Sodium Ascorbate by Reversed Phase-High Performance Liquid Chromatography. Asian Journal of Chemistry, 34(9), 2227–2234. https://doi.org/10.14233/ajchem.2022.23803
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. W.N. Haworth and E.L. Hirst, Chem. Ind., 52, 645 (1933); https://doi.org/10.1002/jctb.5000523107
  2. A.N. Hiatt, M.G. Ferruzzi, L.S. Taylor and L.J. Mauer, Int. J. Food Prop., 14, 1330 (2011); https://doi.org/10.1080/10942911003650338
  3. H. Sohi, Y. Sultana and R.K. Khar, Drug Dev. Ind. Pharm., 30, 429 (2004); https://doi.org/10.1081/DDC-120037477
  4. X. Yin, K. Chen, H. Cheng, X. Chen, S. Feng, Y. Song and L. Liang, Antioxidants, 11, 153 (2022); https://doi.org/10.3390/antiox11010153
  5. S.J. Devaki, R.L.Raveendran and A.H. Hamza, Vitamin C: Sources, Functions, Sensing and Analysis, IntechOpen (2017); https://doi.org/10.5772/intechopen.70162
  6. K. Pathy, SF J. Chem. Res., 2, 1 (2018); https://doi.org/10.32474/SCSOAJ.2018.01.000114
  7. B. Marriott, D. Birt, V. Stallings and A. Yates, Vitamin C, Present Knowledge in Nutrition, Academic Press London, pp. 155-170 (2020).
  8. M.W. Davey, M.V. Montagu, D. Inze, M. Sanmartin, N. Smirnoff, I.J. Benzie, A. Kanellis, J.J. Strain, D. Favell and J. Fletcher, J. Sci. Food Agric., 80, 825 (2000); https://doi.org/10.1002/(SICI)1097-0010(20000515)80:7<825::AIDJSFA598>3.0.CO;2-6
  9. E. Magiorkinis, A. Beloukas and A. Diamantis, Eur. J. Intern. Med., 22, 147 (2011); https://doi.org/10.1016/j.ejim.2010.10.006
  10. R.L. Schleicher, M.D. Carroll, E.S. Ford and D.A. Lacher, Am. J. Clin. Nutr., 90, 1252 (2009); https://doi.org/10.3945/ajcn.2008.27016
  11. H. Hemila and E. Chalker, Cochrane Database Syst. Rev., 2013, CD000980 (2013); https://doi.org/10.1002/14651858.CD000980.pub4
  12. P. Vorilhon, B. Arpajou, H. Vaillant Roussel, É. Merlin, B. Pereira and A. Cabaillot, Eur. J. Clin. Pharmacol., 75, 303 (2019); https://doi.org/10.1007/s00228-018-2601-7
  13. R.Z. Cheng, Med. Drug Discovery, 5, 100028 (2020); https://doi.org/10.1016/j.medidd.2020.100028
  14. G.P. Milani, M. Macchi and A. Guz-Mark, Nutrients, 13, 1172 (2021); https://doi.org/10.3390/nu13041172
  15. B.V. Sunil Kumar, S. Singh and R. Verma, Crit. Rev. Food Sci. Nutr., 57, 2623 (2017); https://doi.org/10.1080/10408398.2015.1064086
  16. D. Mastrangelo, L. Massai, G. Fioritoni and F.L. Coco, Eds.: A.H. Hamza, Vitamin C Against Cancer, Intech Open (2017); https://doi.org/10.5772/intechopen.68746
  17. F.E. Harrison, J. Alzheimers Dis., 29, 711 (2012); https://doi.org/10.3233/JAD-2012-111853
  18. K. Yoshii, K. Hosomi, K. Sawane and J. Kunisawa, Front. Nutr., 6, 48 (2019); https://doi.org/10.3389/fnut.2019.00048
  19. C.L. Linster and E. Van Schaftingen, FEBS J., 274, 1 (2007); https://doi.org/10.1111/j.1742-4658.2006.05607.x
  20. J.S. Goodwin and M.R. Tangum, Arch. Intern. Med., 158, 2187 (1998); https://doi.org/10.1001/archinte.158.20.2187
  21. K.A. Naidu, Nutr. J., 2, 7 (2003); https://doi.org/10.1186/1475-2891-2-7
  22. L.D.K. Thomas, C.G. Elinder, H.G. Tiselius, A. Wolk and A. Akesson, JAMA Intern. Med., 173, 386 (2013); https://doi.org/10.1001/jamainternmed.2013.2296
  23. Y. Kim and M.G. Kim, TCP, 24, 37 (2016); https://doi.org/10.12793/tcp.2016.24.1.37
  24. L. Lloyd, Analysis of the Purity and Storage Stability of L-Ascorbic Acid Powders. Application Note, Agilent Technologies, Inc. (2011); https://www.agilent.com/cs/library/applications/5990-8162EN.pdf
  25. Z.D. Clark and E.L. Frank, Pract. Lab. Med., 6, 25 (2016); https://doi.org/10.1016/j.plabm.2016.09.001
  26. Z. Gazdik, O. Zitka, J. Petrlova, V. Adam, J. Zehnalek, A. Horna, V. Reznicek, M. Beklova and R. Kizek, Sensors (Basel), 8, 7097 (2008); https://doi.org/10.3390/s8117097
  27. L. Yang, L. Liu, B.A. Olsen and M.A. Nussbaum, J. Pharm. Biomed. Anal., 22, 487 (2000); https://doi.org/10.1016/S0731-7085(00)00230-2
  28. I.C.H. Guideline, Q2(R1) Validation of Analytical Procedures: Text and Methodologies, International Conference on Harmonization, IFPMA, Geneva (2005).
  29. The United States Pharmacopeia, Validation of Compendial Methods, Ed.: 35 (2017).
  30. R. LoBrutto, A. Jones, Y.V. Kazakevich and H.M. McNair, J. Chromatogr. A, 913, 173 (2001); https://doi.org/10.1016/S0021-9673(00)01012-8
  31. M. Bakshi and S. Singh, J. Pharm. Biomed. Anal., 28, 1011 (2001); https://doi.org/10.1016/S0731-7085(02)00047-X
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0